Target intelligence / Profile preview

Adrenergic alpha₂-C receptor (None)

Target
None
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

The adrenergic alpha2C receptor (ADRA2C) is a G protein-coupled receptor (GPCR) that plays a key role in regulating neurotransmitter release from sympathetic nerves and central nervous system adrenergic neurons. It is primarily involved in the inhibition of adenylate cyclase, leading to decreased cAMP levels within cells. The alpha 2C subtype modulates neurotransmission at lower levels of nerve activity due to its higher affinity for norepinephrine and slower deactivation kinetics. High expression or altered function has been associated with pathogenesis such as preeclampsia and fetal growth restriction. Its broad CNS distribution suggests roles at multiple brain levels relevant for neuropsychiatric research.

Other names
ADRA2CADRA2L2ADRA2RL2Alpha-2 adrenergic receptor subtype C4Alpha-2C adrenoceptorAlpha-2CAR
02

Mechanism of action

Agonist or antagonist binding to the receptor, modulating downstream signaling pathways such as adenylate cyclase inhibition via Gi/o proteins.

03

Biological functions

Signal transductionInhibition of adenylate cyclase activityNegative regulation of insulin secretionRegulation of smooth muscle contractionRegulation of vasoconstrictionPositive regulation of MAPK cascadeNeurotransmission modulation
04

Disease associations

PreeclampsiaFetal growth restrictionNeuropsychiatric disorders
05

Interacting drugs

Norepinephrine

12 more in the full profile.

Beyond the preview

Go deeper on Adrenergic alpha₂-C receptor (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrenergic alpha₂-C receptor (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call